|
|
||||||||
Journal of Lipid Research, Vol 36, 1987-1995, Copyright © 1995 by Lipid Research, Inc.
K Nonogaki, AH Moser, XM Pan, I Staprans, C Grunfeld and KR Feingold
The host response to infection is frequently accompanied by changes in
lipid metabolism. Previous studies have shown that endotoxin (LPS), a
component of the cell wall of gram-negative bacteria, increases serum lipid
levels. In this study, we demonstrate that lipoteichoic acid (LTA), a
component of the cell membrane of gram-positive bacteria, also increases
serum lipid levels in rats in a dose-dependent manner (0.1- 300
micrograms/200 g body weight). Serum triglyceride levels increased within 2
h after LTA administration with peak values at 4 h (2-fold increase). Serum
cholesterol levels also increased but the effect was delayed occurring at
16 h and was relatively small (1.2-fold increase). LTA (10 micrograms/200 g
BW) did not decrease adipose tissue lipoprotein lipase activity or the
clearance of triglyceride-rich lipoproteins. Rather, the LTA-induced
hypertriglyceridemia is due to an increase in hepatic triglyceride
secretion. LTA stimulates both hepatic de novo fatty acid synthesis and
lipolysis. The increased delivery of free fatty acids to the liver plays a
major role in the LTA-induced hypertriglyceridemia. Pretreatment with
phentolamine, an alpha- adrenergic receptor antagonist, and alprenolol, a
beta-adrenergic receptor antagonist, or phentolamine alone significantly
suppressed the hypertriglyceridemia induced by LTA. These adrenergic
inhibitors had no significant effect on the increase in lipolysis. These
results indicate that catecholamines are involved in mediating the
LTA-induced increase in hepatic triglyceride secretion via alpha-adrenergic
receptors. These changes in lipid metabolism may play an important role in
the organism's response to gram-positive infection.
ARTICLES
Lipoteichoic acid stimulates lipolysis and hepatic triglyceride secretion in rats in vivo
Department of Medicine, University of California, San Francisco, 94143, USA.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. R. Feingold, Y. Wang, A. Moser, J. K. Shigenaga, and C. Grunfeld LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney J. Lipid Res., October 1, 2008; 49(10): 2179 - 2187. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Vodovotz, Shubing Liu, C. McCloskey, R. Shapiro, A. Green, and T. R. Billiar The hepatocyte as a microbial product-responsive cell Innate Immunity, October 1, 2001; 7(5): 365 - 373. [Abstract] [PDF] |
||||
![]() |
C. Grunfeld, M. Marshall, J. K. Shigenaga, A. H. Moser, P. Tobias, and K. R. Feingold Lipoproteins inhibit macrophage activation by lipoteichoic acid J. Lipid Res., February 1, 1999; 40(2): 245 - 252. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |